Novo Nordisk hikes outlook on hovering demand for Wegovy, Ozempic
Novo Nordisk on Friday raised its outlook for its full-year sales and operating profit due to soaring demand for its blockbuster weight loss drug Wegovy and…
Recover your password.
A password will be e-mailed to you.